Gardiquimod


Gardiquimod is an experimental drug which acts selectively at both mouse and human forms of toll-like receptor 7. It functions as an immune response modifier. The core structure is 1H-imidazoquinoline, as found in related drugs such as imiquimod and resiquimod. It is structurally very similar to resiquimod differing only by an oxygen for nitrogen switch.